Endonuclease substrate selectivity characterized with full-length PA of influenza A virus polymerase

Erin Noble1, Andrew Cox, Jerome Deval

  • 1Department of Microbiology and Immunology, University of Rochester, Rochester, NY 14642, USA.

Virology
|July 31, 2012
PubMed

Insights

The influenza A PA protein acts as an endonuclease, cleaving RNA and DNA. This study characterized its activity, revealing crucial details for designing new antiviral inhibitors.

Area of Science:

  • Virology
  • Molecular Biology
  • Biochemistry

Background:

  • Influenza A polymerase is essential for viral transcription and replication.
  • The PA subunit's N-terminal domain exhibits endonuclease activity.
  • Understanding PA endonuclease function is key for antiviral drug development.

Purpose of the Study:

  • To biochemically characterize the endonuclease activity of full-length influenza A PA protein.
  • To develop an improved assay for studying PA endonuclease function.
  • To identify key properties of PA for inhibitor design.

Main Methods:

  • Developed an improved in vitro assay using full-length PA protein.
  • Assessed activity against RNA and DNA substrates.
  • Investigated cofactor requirements (divalent cations) and substrate characteristics (size, sequence selectivity).
  • Confirmed endonuclease activity using a FRET-based assay.

Main Results:

  • Full-length PA protein exhibits cap-independent endonuclease activity on both RNA and DNA.
  • Activity is modulated by divalent cations, influencing PA secondary structure.
  • Determined the minimal substrate size and sequence selectivity of PA.
  • Confirmed PA endonuclease activity in vitro.

Conclusions:

  • The PA endonuclease is a versatile enzyme with RNA and DNA cleavage capabilities.
  • Characterization provides critical insights into substrate requirements and cofactor dependency.
  • Findings are vital for the rational design of influenza A antiviral inhibitors targeting PA.